Advancing Precision Ophthalmology: Human Retinal Organoids as Platforms for Disease Modeling and Personalized Therapy
Organoids · 11.11.2026 · 5 (4) · 39
DOI: 10.3390/organoids5040039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organoids, online erschienen am 11.11.2026. Verfasst von Evan Paul Zelt und 6 weiteren Autor:innen. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NEI, DoD, Translational Eye and Vision Research Center.
Abstract (Originalsprache)
Human-induced pluripotent stem cell (hiPSC)-derived retinal organoids (ROs) have emerged as a transformative 3D in vitro model that closely recapitulates human retinogenesis and the layered cellular architecture of the native retina. This review highlights their profound utility as a precision platform for ophthalmic research. ROs, particularly those derived from patients with inherited retinal diseases (IRDs), provide an effective model for investigating disease pathogenesis, while retaining the patient’s genetic background. This specificity is crucial for the modeling of monogenic disorders like Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) and complex conditions like Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR), and battle-related ocular trauma in the battlefield. Furthermore, ROs serve as a scalable and high-throughput tool for drug screening and toxicology testing, accelerating the identification of therapeutic compounds. Finally, they represent a renewable source for generating purified, functional retinal cells (e.g., photoreceptors and retinal ganglion cells) for precision cell therapies aimed at retinal repair. While challenges remain in achieving true vascularization and long-term maturation, RO technology is poised to rapidly advance personalized medicine and curative strategies for blinding retinal disorders.
Förderung
- NIH/NEI
- DoD
- Translational Eye and Vision Research Center
Zitieren
APA
Zelt, E. P., Singh, S., Seiler, M. J., Huang, H., Atala, A., Ma, J., & Zhang, Y. (2026). Advancing Precision Ophthalmology: Human Retinal Organoids as Platforms for Disease Modeling and Personalized Therapy. Organoids, 5(4), 39. https://doi.org/10.3390/organoids5040039
Vancouver
Zelt EP, Singh S, Seiler MJ, Huang H, Atala A, Ma J, et al. Advancing Precision Ophthalmology: Human Retinal Organoids as Platforms for Disease Modeling and Personalized Therapy. Organoids. 2026;5(4):39. doi:10.3390/organoids5040039
BibTeX
@article{Zelt2026,
author = {Zelt, Evan Paul and Singh, Sachdeep and Seiler, Magdalene J. and Huang, Hu and Atala, Anthony and Ma, Jian-Xing and Zhang, Yuanyuan},
title = {Advancing Precision Ophthalmology: Human Retinal Organoids as Platforms for Disease Modeling and Personalized Therapy},
journal = {Organoids},
year = {2026},
volume = {5},
number = {4},
pages = {39},
doi = {10.3390/organoids5040039}
}
EUVIMED